Literature DB >> 16862241

The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Fannie St-Gelais1, Claudia Jomphe, Louis-Eric Trudeau.   

Abstract

The peptide neurotensin has been studied for more than 30 years. Although it is widely distributed in the central and peripheral nervous systems, neurotensin has been more intensely studied with regard to its interactions with the central dopamine system. A number of claims have been made regarding its possible implication in many diseases of the central nervous system, including schizophrenia. In this review, we describe briefly the basic biology of this neuropeptide, and then we consider the strengths and the weaknesses of the data that suggest a role for neurotensin in schizophrenia, drug abuse, Parkinson's disease, pain, central control of blood pressure, eating disorders, cancer, neurodegenerative disorders and inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862241      PMCID: PMC1488904     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  334 in total

1.  Pharmacological, molecular and functional characterization of glial neurotensin receptors.

Authors:  D Nouel; P Sarret; J P Vincent; J Mazella; A Beaudet
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area.

Authors:  T R Werkman; C G Kruse; H Nievelstein; S K Long; W J Wadman
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle.

Authors:  D Feifel; T L Reza
Journal:  Behav Brain Res       Date:  1999-12       Impact factor: 3.332

4.  Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties.

Authors:  M Boules; B McMahon; L Warrington; J Stewart; J Jackson; A Fauq; D McCormick; E Richelson
Journal:  Brain Res       Date:  2001-11-16       Impact factor: 3.252

5.  Neurotensin depolarizes cholinergic and a subset of non-cholinergic septal/diagonal band neurons by stimulating neurotensin-1 receptors.

Authors:  R T Matthews
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Neurotensin-containing pathway from the endopiriform nucleus and the adjacent prepiriform cortex to the dorsomedial thalamic nucleus in the rat.

Authors:  S Inagaki; Y Kubota; K Shinoda; Y Kawai; M Tohyama
Journal:  Brain Res       Date:  1983-01-31       Impact factor: 3.252

7.  Neurotensin modulates human neutrophil locomotion and phagocytic capability.

Authors:  R Goldman; Z Bar-Shavit; D Romeo
Journal:  FEBS Lett       Date:  1983-08-08       Impact factor: 4.124

8.  Evidence for the existence of a neurotensin-containing pathway from the endopiriform nucleus and the adjacent prepiriform cortex to the anterior olfactory nucleus and nucleus of diagonal band (Broca) of the rat.

Authors:  S Inagaki; K Shinoda; Y Kubota; S Shiosaka; T Matsuzaki; M Tohyama
Journal:  Neuroscience       Date:  1983-03       Impact factor: 3.590

9.  Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.

Authors:  P W Kalivas; S K Burgess; C B Nemeroff; A J Prange
Journal:  Neuroscience       Date:  1983-03       Impact factor: 3.590

10.  Neurotensin: topographical distribution in rat brain by immunohistochemistry.

Authors:  L Jennes; W E Stumpf; P W Kalivas
Journal:  J Comp Neurol       Date:  1982-09-20       Impact factor: 3.215

View more
  55 in total

1.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

2.  Neurotensinergic Excitation of Dentate Gyrus Granule Cells via Gαq-Coupled Inhibition of TASK-3 Channels.

Authors:  Haopeng Zhang; Hailong Dong; Nicholas I Cilz; Lalitha Kurada; Binqi Hu; Etsuko Wada; Douglas A Bayliss; James E Porter; Saobo Lei
Journal:  Cereb Cortex       Date:  2014-11-18       Impact factor: 5.357

3.  Neurotensinergic augmentation of glutamate release at the perforant path-granule cell synapse in rat dentate gyrus: Roles of L-Type Ca²⁺ channels, calmodulin and myosin light-chain kinase.

Authors:  Haopeng Zhang; Hailong Dong; Saobo Lei
Journal:  Neuropharmacology       Date:  2015-04-02       Impact factor: 5.250

4.  Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.

Authors:  Jae Hun Shin; Kyung-Mi Lee; Jimin Shin; Kui Dong Kang; Chu Won Nho; Yoon Shin Cho
Journal:  Genes Genomics       Date:  2019-02-14       Impact factor: 1.839

5.  The influence of oligopeptides on spontaneous carcinogenesis in mice.

Authors:  V K Meshavkin; N V Kost; O Yu Sokolov; L A Andreeva; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2013-05-08

6.  Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.

Authors:  Srinidhi Jayaraman; Abdullah Al Shoyaib; Joanna Kocot; Heidi Villalba; Faisal F Alamri; Mamoon Rashid; Naomi J Wangler; Ekram A Chowdhury; Nadezhda German; Thiruma V Arumugam; Thomas J Abbruscato; Vardan T Karamyan
Journal:  J Neurochem       Date:  2019-10-22       Impact factor: 5.372

7.  Neurotensin induces hypothermia by activating both neuronal neurotensin receptor 1 and astrocytic neurotensin receptor 2 in the median preoptic nucleus.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2020-04-08       Impact factor: 5.250

8.  Intrathecal neurotensin is hypotensive, sympathoinhibitory and enhances the baroreflex in anaesthetized rat.

Authors:  B Zogovic; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

9.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

10.  Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.

Authors:  Charbel S Fawaz; Philippe Martel; Damiana Leo; Louis-Eric Trudeau
Journal:  BMC Neurosci       Date:  2009-08-14       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.